Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
636
datasets available to search
ShareScore release 0.9.0
Dataset results
636 results for “Chimerism”
Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT
ClinicalTrials.gov study NCT00840853. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of Chimeric Monoclonal Antibodies to Shiga Toxins 1 and 2
ClinicalTrials.gov study NCT01252199. IPD Sharing: Not stated. Countries: 3. Publications: 2.
Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03971799. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Feasibility and Safety of UCD19 Chimeric Antigen Receptor (CAR) T Cells in Adult Subjects With Relapsed/Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (B-NHL)
ClinicalTrials.gov study NCT04240808. IPD Sharing: NO. Countries: 1. Publications: 0.
Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas
ClinicalTrials.gov study NCT06964737. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Immunogenicity of a Chimeric Recombinant Covid19 Vaccine SpiN-Tec MCTI UFMG
ClinicalTrials.gov study NCT07134725. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Autologous T Cells Redirected to EGFRVIII-With a Chimeric Antigen Receptor in Patients With EGFRVIII+ Glioblastoma
ClinicalTrials.gov study NCT02209376. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors
ClinicalTrials.gov study NCT03302403. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients With AL Amyloidosis
ClinicalTrials.gov study NCT02245867. IPD Sharing: YES. Countries: 1. Publications: 17.
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201
ClinicalTrials.gov study NCT04422912. IPD Sharing: NO. Countries: 1. Publications: 0.
Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies
ClinicalTrials.gov study NCT02456350. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of LCAR-B38M CAR-T Cells, a Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Chinese Participants With Relapsed or Refractory Multiple Myel
ClinicalTrials.gov study NCT03758417. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety Study of Chimeric Antigen Receptor Modified T-cells Targeting NKG2D-Ligands
ClinicalTrials.gov study NCT02203825. IPD Sharing: Not stated. Countries: 1. Publications: 1.
High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressiv
ClinicalTrials.gov study NCT01840566. IPD Sharing: Not stated. Countries: 1. Publications: 2.
KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Treatment Refractory Stiff Person Syndrome
ClinicalTrials.gov study NCT06588491. IPD Sharing: NO. Countries: 1. Publications: 2.
KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic Sclerosis
ClinicalTrials.gov study NCT06400303. IPD Sharing: NO. Countries: 1. Publications: 1.
Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT04545762. IPD Sharing: NO. Countries: 1. Publications: 1.
Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gliomas
ClinicalTrials.gov study NCT03423992. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients
ClinicalTrials.gov study NCT00085930. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of CC-97540, CD19-targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, in Subjects With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT04231747. IPD Sharing: YES. Countries: 2. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.